<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505139</url>
  </required_header>
  <id_info>
    <org_study_id>SYSUCCCTC</org_study_id>
    <nct_id>NCT02505139</nct_id>
  </id_info>
  <brief_title>The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients</brief_title>
  <official_title>Using Circulating Tumor Cells to Diagnose and Predict Prognosis in Metastatic Nasopharyngeal Carcinoma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A circulating tumor cell (CTC) count is an established prognostic factor in some malignancies
      such as metastatic breast cancer. However, the value of CTC in diagnosis and outcome
      prediction of metastatic nasopharyngeal carcinoma (mNPC) patients is not unknown. Through the
      observational prospective clinical trial, sensitivity, specificity, positive and negative
      predictive values of CTC in diagnosis of mNPC patients will be gained. Further, the value of
      CTC in outcome prediction of mNPC patients will be uncovered.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival rate</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The proportion of positives that are correctly identified as such</measure>
    <time_frame>3 years</time_frame>
    <description>number of true positives divided by (number of true positives plus number of false negatives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of negatives that are correctly identified as such</measure>
    <time_frame>3 years</time_frame>
    <description>number of true negatives divided by (number of true negatives plus number of false positives)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportions of positive results in statistics and diagnostic tests that are true positive results.</measure>
    <time_frame>3 years</time_frame>
    <description>number of true positives divided by number of positive calls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportions of negative results in statistics and diagnostic tests that are true negative results.</measure>
    <time_frame>3 years</time_frame>
    <description>number of true negatives divided by number of negative calls</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">166</enrollment>
  <condition>Nasopharyngeal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>the number of circulating tumor cells</intervention_name>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The blood after separation and purification along with or without CTC.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        NPC patients with distant metastasis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically or radiologically confirmed nasopharyngeal non-keratinizing carcinoma
             (WHO II, III).

          -  NPC patients with distant metastasis including synchronous distant metastasis at
             diagnosis and metachronous distant metastasis after radical treatment.

          -  A Karnofsky performance status score more than 70.

          -  The participants provided written informed consent.

        Exclusion Criteria:

          -  A history of previous or synchronous malignant tumors.

          -  Suffering from severe mental illness synchronously.

          -  Suffering from severe heart or lung diseases.

          -  Obvious abnormality in liver and renal function.

          -  Women in pregnancy or breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ming-Yuan Chen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sun Yat-sen University</affiliation>
  </overall_official>
  <results_reference>
    <citation>Smerage JB, Barlow WE, Hortobagyi GN, Winer EP, Leyland-Jones B, Srkalovic G, Tejwani S, Schott AF, O'Rourke MA, Lew DL, Doyle GV, Gralow JR, Livingston RB, Hayes DF. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J Clin Oncol. 2014 Nov 1;32(31):3483-9. doi: 10.1200/JCO.2014.56.2561. Epub 2014 Jun 2.</citation>
    <PMID>24888818</PMID>
  </results_reference>
  <results_reference>
    <citation>Zhang Z, Shiratsuchi H, Lin J, Chen G, Reddy RM, Azizi E, Fouladdel S, Chang AC, Lin L, Jiang H, Waghray M, Luker G, Simeone DM, Wicha MS, Beer DG, Ramnath N, Nagrath S. Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model. Oncotarget. 2014 Dec 15;5(23):12383-97.</citation>
    <PMID>25474037</PMID>
  </results_reference>
  <results_reference>
    <citation>Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LW. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005 Mar 1;23(7):1420-30. Erratum in: J Clin Oncol. 2005 Jul 20;23(21):4808.</citation>
    <PMID>15735118</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2015</study_first_submitted>
  <study_first_submitted_qc>July 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>August 25, 2016</last_update_submitted>
  <last_update_submitted_qc>August 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Ming-Yuan Chen</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>nasopharyngeal carcinoma</keyword>
  <keyword>distant metastasis</keyword>
  <keyword>circulating tumor cells</keyword>
  <keyword>outcome prediction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplastic Cells, Circulating</mesh_term>
    <mesh_term>Nasopharyngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

